ATAP Urges Congress: Reform PBMs, Not Import Foreign Drug Prices
ATAP has submitted a letter to Congress urging lawmakers to reject the Most Favored Nations (MFN) drug pricing proposal. Instead, we call for real reform that holds pharmacy benefit managers (PBMs) accountable and puts patients first.
https://atapadvocates.com/s/ATAP-MFN-Federal-Comments-Senate-Reconciliation-06-09-2025-Website.pdf